API Innovation Center calls for government intervention to boost domestic drug production

A local nonprofit working to strengthen the U.S. drug ingredient supply chain says external forces are making drug shortages ...

Novartis buys antibiotics business from GSK in generics push

Swiss drugmaker Novartis' <a href=" target="_blank">(NOVN.S) generics division is buying a GlaxoSmithKline <a href=" target="_blank">(GSK.L) antibiotics business that includes the brands Zinnat, ...
TipRanks on MSN

Ligand partner SQ Innovation receives approval from FDA for Lasix ONYU

Pharmaceuticals announced that its partner SQ Innovation has received approval from the U.S. Food and Drug Administration, FDA, for ...
AlphaGalileo

KAIST Exports Global License for New Drug Candidate for Intractable Epilepsy Worth 750 Billion KRW

KAIST (President Kwang Hyung Lee) announced on the 9th of October that Sovargen (co-led by CEOs Cheolwon Park and Jeong Ho ...
Pharmaceutical Commerce

Pharma Accelerates AI Adoption as Transparency and Traceability Take Center Stage

In the second part of his Pharma Commerce video interview, Shawn Opatka, VP and GM, Honeywell Life Sciences, notes that nearly all pharma organizations are experimenting with AI to address labor ...
Life Sciences IP Review

Brazil’s patent shakeup: How pharma is handling a new reality

A 2021 Supreme Court ruling changed how patent terms are calculated, forcing pharma companies to rethink their IP strategies.